acetazolamide and u-104
acetazolamide has been researched along with u-104 in 26 studies
Research
Studies (26)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 12 (46.15) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Carta, F; Pacchiano, F; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
| Carta, F; Dedhar, S; Lou, Y; McDonald, PC; Pacchiano, F; Scozzafava, A; Supuran, CT; Vullo, D | 1 |
| Balboni, G; Congiu, C; Dedeoglu, N; Deplano, A; Onnis, V; Supuran, CT | 1 |
| Carta, F; Lomelino, CL; Mahon, BP; McKenna, R; Supuran, CT | 1 |
| Abdel-Aziz, HA; Abou El Ella, DA; Abou-Seri, SM; Ceruso, M; Eldehna, WM; Fares, M; Ghabbour, HA; Supuran, CT | 1 |
| Abdel Gawad, NM; Amin, NH; Angeli, A; Capasso, C; De Luca, V; Elsaadi, MT; Mohamed, FMM; Supuran, CT | 1 |
| AlOthman, Z; Carta, F; Osman, SM; Supuran, CT; Vullo, D | 1 |
| Angeli, A; Bartolucci, G; Carta, F; Supuran, CT | 1 |
| Angeli, A; Bartolucci, G; Capperucci, A; Carta, F; Di Cesare Mannelli, L; Ghelardini, C; Peat, TS; Supuran, CT; Tanini, D | 1 |
| Bozdag, M; Carta, F; Ceruso, M; Dedhar, S; Ferraroni, M; McDonald, PC; Supuran, CT | 1 |
| Bartolucci, G; Di Cesare Mannelli, L; Ghelardini, C; Gratteri, P; Lomelino, CL; McKenna, R; Nocentini, A; Singh, S; Supuran, CT; Trallori, E | 1 |
| Abdel-Aziz, HA; Abo-Ashour, MF; Al-Rashood, ST; Bonardi, A; Bua, S; El-Haggar, RS; Eldehna, WM; Gratteri, P; Hassan, GS; Nocentini, A; Supuran, CT | 1 |
| Akocak, S; Bua, S; Lolak, N; Sanku, RKK; Supuran, CT | 1 |
| Abdel-Aziz, AA; Alanazi, MM; Almehizia, AA; AlSaif, NA; Bua, S; El-Azab, AS; Hefnawy, MM; Nocentini, A; Supuran, CT | 1 |
| Abdel-Aziz, HA; Abou-Seri, SM; Bonardi, A; Bua, S; Eldehna, WM; Fahim, SH; Gratteri, P; Nocentini, A; Said, MA; Soliman, DH; Supuran, CT | 1 |
| Jaswal, S; Kumar, S; Monga, V; Rulhania, S | 1 |
| Andring, J; Combs, J; Frost, SC; Mboge, MY; McKenna, R; Singh, S; Tu, C; Wolff, A; Zhang, Z | 1 |
| Angeli, A; Bua, S; Kumari, S; Mishra, CB; Mongre, RK; Supuran, CT; Tiwari, M | 1 |
| Abdel-Aziz, HA; Abdelgawad, MA; Abo-Ashour, MF; Al-Sanea, MM; Alharbi, KS; Elbadawi, MM; Eldehna, WM; Elkaeed, EB; Gratteri, P; Nocentini, A; Supuran, CT | 1 |
| Angeli, A; Carta, F; Da'dara, AA; Ferraroni, M; Pinteala, M; Selleri, S; Skelly, PJ; Supuran, CT | 1 |
| Abdel-Aziz, HA; Abdelfadil, M; Badria, FA; Bonardi, A; El-Domany, RA; Eldehna, WM; Elgazar, AA; Elimam, DM; Nocentini, A; Supuran, CT | 1 |
| Al-Rashood, ST; Allam, HA; Bonardi, A; Elaasser, MM; Eldehna, WM; Elimam, DM; Gratteri, P; Nocentini, A; Salem, R; Supuran, CT | 1 |
| Andring, J; Angeli, A; Bartolucci, G; Carta, F; Combs, J; Ferraroni, M; Lomelino, C; Lucarini, L; Masini, E; Mckenna, R; Pallecchi, M; Sgambellone, S; Supuran, CT; Vannozzi, G; Vullo, D | 1 |
| Abdel-Aziz, HA; Al-Rashood, ST; El Hassab, MA; Elbadawi, MM; Eldehna, WM; Elkaeed, EB; Fares, M; Nocentini, A; Somaa, WR; Supuran, CT | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Abbas, SE; Allam, HA; Awadallah, FM; Mahmoud, WR; Oudah, KH; Supuran, CT; Taher, AT; Vullo, D | 1 |
Reviews
1 review(s) available for acetazolamide and u-104
| Article | Year |
|---|---|
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors.
Topics: Acetazolamide; Animals; Antineoplastic Agents; Antioxidants; Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Indoles; Isatin; Molecular Docking Simulation; Organoselenium Compounds; Oxadiazoles; Protein Binding; Protein Isoforms; Pyrimidines; Structure-Activity Relationship; Sulfonamides; Thiazines; Thiophenes; Urea | 2021 |
Other Studies
25 other study(ies) available for acetazolamide and u-104
| Article | Year |
|---|---|
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides.
Topics: Benzenesulfonamides; Candida albicans; Carbonic Anhydrase II; Enzyme Inhibitors; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfonamides | 2011 |
Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Benzene Derivatives; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; Female; Humans; Isoenzymes; Mammary Neoplasms, Experimental; Mice; Models, Molecular; Neoplasm Metastasis; Nitrobenzenes; Protein Binding; Structure-Activity Relationship; Sulfonamides; Urea | 2011 |
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Piperazine; Piperazines; Structure-Activity Relationship; Sulfonamides | 2015 |
Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Halogenation; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Protein Isoforms; Structure-Activity Relationship; Sulfonamides; Thiourea | 2016 |
Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isatin; Protein Isoforms; Structure-Activity Relationship; Sulfonamides; Urea | 2016 |
Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.
Topics: Antineoplastic Agents; Benzenesulfonamides; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Proliferation; Cell Survival; Drug Delivery Systems; Female; Humans; Inhibitory Concentration 50; MCF-7 Cells; Molecular Structure; Sulfonamides; Thiazoles | 2016 |
Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
Topics: Acetazolamide; Antineoplastic Agents; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Phenylurea Compounds; Structure-Activity Relationship; Sulfonamides | 2017 |
Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship; Sulfonamides | 2017 |
Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors.
Topics: | 2017 |
Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Catalytic Domain; Cell Line, Tumor; Drug Design; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Phenylurea Compounds; Sulfonamides; Tumor Hypoxia | 2018 |
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Tumor Hypoxia | 2018 |
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Catalytic Domain; Cell Cycle; Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Isatin; Molecular Docking Simulation; Phenylurea Compounds; Protein Binding; Sulfonamides; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Topics: Antineoplastic Agents; Benzenesulfonamides; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Structure-Activity Relationship; Sulfonamides; Triazines | 2019 |
New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
Topics: Benzene Derivatives; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Molecular Docking Simulation; Sulfonamides | 2019 |
Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors.
Topics: Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Dynamics Simulation; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Sulfonamides; Triazoles | 2020 |
Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Hydrogen-Ion Concentration; Models, Molecular; Triple Negative Breast Neoplasms | 2021 |
Discovery of Potent Carbonic Anhydrase Inhibitors as Effective Anticonvulsant Agents: Drug Design, Synthesis, and In Vitro and In Vivo Investigations.
Topics: Animals; Anticonvulsants; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Drug Design; Drug Discovery; Epilepsy; Humans; Male; Rats, Wistar | 2021 |
Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities.
Topics: Amides; Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isoenzymes; Molecular Structure; Phenylurea Compounds; Structure-Activity Relationship; Sulfonamides | 2021 |
Structural Insights into
Topics: Animals; Benzene Derivatives; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Models, Molecular; Molecular Structure; Organoselenium Compounds; Schistosoma mansoni; Structure-Activity Relationship; Sulfonamides | 2021 |
Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation.
Topics: Antineoplastic Agents; Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carboxylic Acids; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2021 |
Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isoenzymes; MCF-7 Cells; Models, Molecular; Molecular Structure; Phenylurea Compounds; Pyrazines; Structure-Activity Relationship; Sulfonamides | 2022 |
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes.
Topics: Animals; Benzenesulfonamides; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Crystallography, X-Ray; Drug Design; Glaucoma; Intraocular Pressure; Male; Models, Molecular; Protein Binding; Rabbits; Structure-Activity Relationship; Sulfonamides | 2022 |
Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors.
Topics: Antigens, Neoplasm; Benzenesulfonamides; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Proliferation; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2022 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Design and synthesis of some new benzoylthioureido benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors.
Topics: Acetazolamide; Benzenesulfonamides; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Molecular Docking Simulation; Molecular Structure; Protein Isoforms; Structure-Activity Relationship | 2023 |